Strategies for the derivation of pluripotent cells from farm animals

Reproduction in Domestic Animals

Volumn 45, Issue SUPPL. 3, 2010, Pages 25-31

  Kues, W A ^a   Nowak Imialek, M ^a   Haridoss, S ^b   Niemann, H ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; MYOD PROTEIN; MYOD1 MYOGENIC DIFFERENTIATION PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX;

ANIMAL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; DOMESTIC ANIMAL; GENE EXPRESSION; GENETICS; NUCLEAR REPROGRAMMING; PHYSIOLOGY; PLURIPOTENT STEM CELL; PRENATAL DEVELOPMENT; SIGNAL TRANSDUCTION; SWINE; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, DOMESTIC; ANIMALS, GENETICALLY MODIFIED; CELL DIFFERENTIATION; CELLS, CULTURED; GENE EXPRESSION; GREEN FLUORESCENT PROTEINS; INDUCED PLURIPOTENT STEM CELLS; MYOD PROTEIN; NUCLEAR REPROGRAMMING; OCTAMER TRANSCRIPTION FACTOR-3; PLURIPOTENT STEM CELLS; SIGNAL TRANSDUCTION; SOXB1 TRANSCRIPTION FACTORS; SWINE;

ANIMALIA; IPS; MURINAE; RATTUS;

EID: 77955248526     PISSN: 09366768     EISSN: 14390531     Source Type: Journal    
DOI: 10.1111/j.1439-0531.2010.01663.x     Document Type: Article

References (76)

1. Bergstrom DA, Penn BH, Strand A, Perry RL, Rudnicki MA, Tapscott SJ. Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression. Mol Cell 2002, 9:587-600.
2. Bosch P, Pratt SL, Stice SL. Isolation, characterization, gene modification, and nuclear reprogramming of porcine mesenchymal stem cells. Biol Reprod 2006, 74:46-57.
3. Braun GB, Pallaoro A, Wu G, Missirlis D, Zasadzinski JA, Tirrell M, Reich NO. Laser-activated gene silencing via gold nanoshell-siRNA conjugates. ASC Nano 2009, 3:2007-2015.
4. Brevini TA, Anonini S, Pennarossa G, Gandolfi F. Recent progress in embryonic stem cell research and its application in domestic species. Reprod Dom Anim 2008, 43(Suppl 2):193-199.
5. Buehr M, Meek S, Blair K, Yang J, Ure J, Silva J, McLay R, Hall J, Ying QL, Smith A. Capture of authentic embryonic stem cells from rat blastocysts. Cell 2008, 135:1287-1298.
6. Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S, Smith A. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 2003, 113:643-645.
7. Chen LR, Shiue YL, Bertolini L, Medrano JF, BonDurant RH, Anderson GB. Establishment of pluripotent cell lines from porcine preimplantation embryos. Theriogenology 1999, 52:195-212.
8. Chin MH, Mason MJ, Xie W, Volinia S, Singer M, Peterson C, Ambartsumyan G, Aimiuwu O, Richter L, Zhang J, Khvorostov I, Ott V, Grunstein M, Lavon N, Benvenisty N, Croce CM, Clark AT, Baxter T, Pyle AD, Teitell MA, Pelegrini M, Plath K, Lowry WE. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 2009, 5:111-123.
9. Cibelli JB, Stice SL, Golueke PJ, Kane JJ, Jerry J, Blackwell C, Ponce de León FA, Robl JM. Transgenic bovine chimeric offspring produced from somatic cell-derived stem-like cells. Nat Biotechnol 1998, 16:642-646.
10. Cossu G, Borello U. Wnt signaling and the activation of myogenesis in mammals. EMBO J 1999, 18:6867-6872.
11. Davis RL, Weintraub H, Lassar AB. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987, 51:987-1000.
12. Esteban MA, Xu J, Yang J, Peng M, Qin D, Li W, Jiang Z, Chen J, Deng K, Zhong M, Cai J, Lai L, Pei D. Generation of induced pluripotent stem cell lines from tibetan miniature pig. J Biol Chem 2009, 284:17634-17640.
13. Evans MJ, Kaufman MH. Establishment in culture of pluripotent cells from mouse embryo. Nature 1981, 292:154-156.
14. Ezashi T, Telugu BP, Alexenko AP, Sachdev S, Sinha S, Roberts RM. Derivation of induced pluripotent stem cells from pig somatic cells. Proc Natl Acad Sci U S A 2009, 106:10993-10998.
15. Gearhart J, Pashos EE, Prasad MK. Pluripotency Redeux - advances in stem-cell research. N Engl J Med 2007, 357:1469-1472.
16. Groeneveld E, Tinh NH, Kues W, Vien NT. A protocol for the cryopreservation of breed by low-cost emergency cell banks - a pilot study. Animal 2008, 2:1-8.
17. Hall V. Porcine embryonic stem cells: a possible source for cell replacement therapy. Stem Cell Rev 2008, 4:275-282.
18. Hanna J, Wernig M, Markoulaki S, Sun CW, Meissner A, Cassady JP, Beard C, Brambrink T, Wu LC, Townes TM, Jaenisch R. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 2007, 318:1920-1923.
19. Haridoss S, Niemann N, Kues W, Moritz T, Cantz T, Martin U, Schambach A, Sgodda M, Jagielska J, Pfaff N, Luettge D, Nowak-Imialek M. Generation and characterisation of porcine induce pluripotent stem cells. Hum Gene Ther 2009, 20:-1523. abstr.)
20. Hochedlinger K, Plath K. Epigenetic reprogramming and induced pluripotency. Development 2009, 136:509-523.
21. Iqbal K, Barg-Kues B, Broll S, Bode J, Niemann H, Kues WA. Cytoplasmic injection of circular plasmids allows targeted expression in mammalian embryos. BioTechniques 2009, 47:959-968.
22. Jun YW, Sheikholeslami S, Hostetter DR, Tajon C, Craik CS, Alivisatos AP. Continuous imaging of plasmon rulers in live cells reveals early -stage caspase-3 activation at the single -molecule level. Proc Natl Acad Sci USA 2009, 106:17735-17740.
23. Keefer CL, Pant D, Blomberg L, Talbot NC. Challenges and prospects for the establishment of embryonic stem cell lines of domesticated ungulates. Animal Reprod Sci 2007, 98:147-168.
24. Kim J, Chu J, Shen X, Wang J, Orkin SH. An extended transcriptional network for pluripotency of embryonic stem cells. Cell 2008a, 132:1049-1061.
25. Kim JB, Zaehres H, Wu G, Gentile L, Ko K, Sebastiano V, Arauzo-Bravo MJ, Ruau D, Han DW, Zenke M, Scholer HR. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 2008b, 454:646-650.
26. Kim JB, Sebastiano V, Wu G, Arauzo-Bravo MJ, Sasse P, Gentile L, Ko K, Ruau D, Ehrich M, van den Boom D, Meyer J, Hubner K, Bernemann C, Ortmeier C, Zenke M, Fleischmann BK, Zaehres H, Scholer HR. Oct4-induced pluripotency in adult neural stem cells. Cell 2009, 136:411-419.
27. Kopp JL, Ormsbee BD, Desler M, Rizzino A. Small increases in the level of Sox2 trigger the differentiation of mouse embryonic stem cells. Stem Cells 2008, 26:903-911.
28. Kues WA, Niemann H. The contribution of farm animals to human health. Trends Biotechnol 2004, 22:286-294.
29. Kues WA, Carnwath JW, Niemann H. From fibroblasts and stem cells: implications for cell therapies and somatic cloning. Reprod Fert Dev 2005, 17:125-134.
30. Kues WA, Sudheer S, Herrmann D. Genome-wide expression profiling reveals distinct clusters of transcriptional regulation during bovine preimplantation in vivo. Proc Natl Acad Sci USA 2008, 105:19768-19773.
31. Kues WA, Garrels W, Mates L, Holler S, Niemann H, Izsvak Z, Ivics Z. Production of transgenic pigs by the Sleeping Beauty transposon system. Transgenic Res. 2010, 19:336-336. abstract
32. Li P, Tong C, Mehrian-Shai R, Jia L, Wu N, Yan Y, Maxson RE, Schulze EN, Song H, Hsieh CL, Pera MF, Ying QL. Germline competent embryonic stem cells derived from rat blastocysts. Cell 2008, 135:1299-1310.
33. Li W, Wei W, Zhu S, Zhu J, Shi Y, Lin T, Hao E, Hayek A, Deng H, Ding S. Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell 2009, 4:16-19.
34. Maherali N, Sridharan R, Xie W, Utikal J, Eminli S, Arnold K, Stadtfeld M, Yachechko R, Tchieu J, Jaenisch R, Plath K, Hochedlinger K. Directly reprogrammed fibroblasts show global epigenetic remodelleling and widespread tissues contribution. Cell Stem Cell 2007, 1:55-70.
35. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned teratocarcinoma stem cells. Proc Natl Acad Sci USA 1981, 78:7634-7638.
36. Martins-Taylor K, Xu RH. Determinants of pluripotency: from avian, rodents, to primates. J Cell Biochem 2010, 109:16-25.
37. Miyamoto K, Furusawa T, Ohnuki M, Goel S, Tokunaga T, Minami N, Yamada M, Ohsumi K, Imai H. Reprogramming events of mammalian somatic cells induced by Xenopus laevis egg extracts. Mol Reprod Dev 2007, 74:1268-1277.
38. Mueller S, Prelle K, Rieger N, Petznek H, Lassnig C, Luksch U, Aigner B, Baetscher M, Wolf E, Mueller M, Brem G. Chimeric pigs following blastocyst injection of transgenic porcine primordial germ cells. Mol Reprod Dev 1999, 54:244-254.
39. Munoz M, Rodriguez A, De Frutos C, Caamano JN, Diez C, Facal N, Gomez E. Conventional pluripotency markers are unspecific for bovine embryonic derived cell-lines. Theriogenology 2008, 69:1159.
40. Munoz M, Trigal B, Molina I, Diez C, Caamano JN, Gomez E. Constraints to progress in embryonic stem cells from domestic species. Stem Cell Rev Rep 2009, 5:6-9.
41. Niwa N, Miyazaki J, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 2000, 24:372-376.
42. Nordhoff V, Hubner K, Bauer A, Orlova I, Malapetsa A, Scholer HR. Comparative analysis of human, bovine, and murine Oct-4 upstream promoter sequences. Mamm Genome 2001, 12:309-317.
43. Nowak-Imialek M, Kues WA, Petersen B, Lucas-Hahn A, Herrmann D, Lemme E, Oropeza M, Carnwath J, Niemann H. Generation of Oct4-GFP transgenic pig lines. Hum Gene Ther 2009, 20:-1525. abstr.)
44. Nowak-Imialek M, Kues WA, Rudolph C, Schlegelberger B, Taylor U, Carnwath JW, Niemann H. Preferential loss of porcine chromosomes in inter-species cell fusions of mouse ES cells and porcine fibroblasts. Cloning and Stem Cells 2010, 12:55-65.
45. Ohmura M, Yoshida S, Ide Y, Nagamatsu G, Suda T, Ohbo K. Spatial analysis of germ stem cell development in Oct-4/EGFP transgenic mice. Arch Histol Cytol 2004, 67:285-296.
46. Pereira CF, Terranova R, Ryan NK, Santos J, Morris KJ, Cui W, Merkenschlager M, Fisher AG. Heterokaryon-based reprogramming of human B lymphocytes for pluripotency requires Oct4 but not Sox2. PLoS Genet 2008, 4:e1000170.
47. Pesce M, Scholer HR. Oct-4: control of totipotency and germline determination. Mol Reprod Dev 2000, 55:452-457.
48. Raff M. Adult stem cell plasticity: fact or artifact. Anuu Rev Cell Dev Biol 2003, 19:1-22.
49. Roberts RM, Telugu BP, Ezashi T. Induced pluripotent stem cells from swine (Sus scrofa): why they may prove to be important. Cell Cycle 2009, 8:3078-3081.
50. Sato N, Meijer L, Skaltsounis L. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med 2004, 10:55-63.
51. Scholer H. Octamania: the POU factors in murine development. Trends Genet 1991, 7:323-329.
52. Scholer HR, Balling R, Hatzopoulos AK, Suzuki N, Gruss P. Octamer binding proteins confer transcriptional activity in early mouse embryogenesis. EMBO J 1989, 8:2551-2557.
53. Scholer H, Ruppert S, Suzuki N, Chowdhury K, Gruss P. New type of POU domain in germ line-specific protein Oct4. Nature 1990, 344:435-439.
54. Smith KP, Luong MX, Stein GS. Pluripotency: toward a gold standard for human ES and iPS cells. J Cell Physiol 2009, 220:21-29.
55. Subramanyam D, Blelloch R. Watching reprogramming in real time. Nat Biotechnol 2009, 11:997-998.
56. Sun W, Wang G, Fang N, Yeung ES. Wavelength-dependent differential interference contrast microscopy: selectively imaging nanoparticle probes in live cells. Anal Chem 2009, 81:9203-9208.
57. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
58. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
59. Takao Y, Yokota T, Koide H. Beta-catenin up-regulates Nanog expression through interaction with Oct3/4 in maintaining pluripotency of mouse ES cells. Biochem Biophys Res Commun 2007, 353:699-705.
60. Talbot NC, Blomberg le A. The pursuit of ES cell lines of domesticated ungulates. Stem Cell Rev 2008, 4:235-254.
61. Tapscott SJ. The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription. Development 2005, 132:2685-2695.
62. Taylor U, Klein S, Petersen S, Kues W, Barcikowski S, Rath D. Non-endosomal cellular uptake of ligand-free, positively charged gold nanoparticles. Cytometry Part A 2010, published online 26 January 2010). DOI 10.1002/cyto.a.20846
63. Vackova I, Ungrova A, Lopes F. Putative embryonic stem cell lines from pig embryos. J Reprod Dev 2007, 53:1137-1149.
64. Vazin T, Schaffer DV. Engineering strategies to emulate the stem cell niche. Trends Biotechnol 2009, publ. ahead of print) DOI 10.1016/j.tibtech.2009.11.008
65. Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, Sudhof TC, Wernig M. Direct conversion of fibroblast to functional neurons by defined factors. Nature 2010, 463:1035-1041.
66. Weintraub H, Tapscott SJ, Davis RL, Thayer MJ, Adam MA, Lassar AB, Miller AD. Activation of muscle-specific genes in pigment, nerve, fat, liver and fibroblast cell lines by forced expression of MyoD. Proc Natl Acad Sci USA 1989, 86:5434-5438.
67. Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hoechedlinger K, Bernstein BE, Jaenisch R. In vitro reprogramming of fibroblasts into a pluripotent ES-cell state. Nature 2007, 448:318-324.
68. Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH. Viable offspring derived from fetal and adult mammalian cells. Nature 1997, 385:810-813.
69. Wu Z, Chen J, Ren J, Bao L, Liao J, Cui C, Rao L, Li H, Gu Y, Dai H, Zhu H, Teng X, Cheng L, Xiao L. Generation of Pig-Induced Pluripotent Stem Cells with a Drug-Inducible System. J Mol Cell Biol 2009, 1:46-54.
70. Wuensch A, Habermann FA, Kurosaka S, Klose R, Zakhartchenko V, Reichenbach HD, Sinowatz F, McLaughlin KJ, Wolf E. Quantitative monitoring of pluripotency gene activation after somatic cloning in cattle. Biol Reprod 2007, 76:983-991.
71. Yadav P, Kues WA, Herrmann D, Carnwath JW, Niemann H. Bovine ICMs express the Oct4 ortholog. Mol Reprod Dev 2005, 72:182-190.
72. Yeom YI, Fuhrmann G, Ovitt CE, Brehm A, Ohbo K, Gross M, Hubner K, Scholer HR. Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells. Development 1996, 122:881-894.
73. Yoshimizu T, Sugiyama N, De Felice M, Yeom YI, Ohbo K, Masuko K, Obinata M, Abe K, Scholer HR, Matsui Y. Germline-specific expression of the Oct-4/green fluorescent protein (GFP) transgene in mice. Dev Growth Differ 1999, 41:75-84.
74. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA. Induced pluripotent stem cell lines derived from human somatic tissue. Science 2007, 318:1917-1920.
75. Yusuf I, Kharas MG, Chen J, Peralta RQ, Maruniak A, Sareen P, Yang VW, Kaestner KH, Fruman DA. KLF4 is a FOXO target gene that suppresses B cell proliferation. Int Immunol 2008, 20:671-681.
76. Zhao XY, Li Z, Lv L, Liu L, Tong M, Hai T, Hao J, Guo CL, MA QW, Wang L, Zeng F, Zhou Q. IPS cells produce viable mice through tetraploid complementation. Nature 2009, 461:86-90.